Statins lower calcium-induced oxidative stress in isolated mitochondria

Human and Experimental Toxicology

Volumn 31, Issue 4, 2012, Pages 355-363

  Parihar, A ^a   Parihar, M S ^b   Zenebe, W J ^c   Ghafourifar, P ^d  

^a Girls Degree College   (India)

^b VIKRAM UNIVERSITY   (India)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Tri State Institute of Pharmaceutical Sciences   (United States)

Author keywords

calcium; mitochondria; mtNOS; nitric oxide; oxidative stress; statin

Indexed keywords

ATORVASTATIN; CALCIUM ION; CYTOCHROME C; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NITRIC OXIDE SYNTHASE; SIMVASTATIN;

ARTICLE; CALCIUM CELL LEVEL; ENZYME ACTIVITY; ENZYME RELEASE; LIPID PEROXIDATION; LIVER MITOCHONDRION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CYTOCHROMES C; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN;

RATTUS;

EID: 84860471028     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111429141     Document Type: Article

References (44)

1. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 1992 ; 33: 1569-1582
2. van der HP, Voors AA, van Gilst WH, Bohm M, van Veldhuisen DJ. Statins in the treatment of chronic heart failure: a systematic review. PLoS Med. 2006 ; 3: 1403-1413 (Pubitemid 44338378)
3. Arnaud C, Burger F, Steffens S, Veillard NR, Nguyen TH, Trono D, et al. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. Arterioscler Thromb Vasc Biol. 2005 ; 25: 1231-1236 (Pubitemid 40776614)
4. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005 ; 45: 89-118 (Pubitemid 40261799)
5. Futterman LG, Lemberg L. Statin pleiotropy: fact or fiction?. Am J Crit Care. 2004 ; 13: 244-249 (Pubitemid 39456745)
6. Davignon J, Jacob RF, Mason RP. The antioxidant effects of statins. Coron Artery Dis. 2004 ; 15: 251-258 (Pubitemid 39061608)
7. Stoll LL, McCormick ML, Denning GM, Weintraub NL. Antioxidant effects of statins. Drugs Today. 2004 ; 40: 975-990
8. Korantzopoulos P, Kokkoris S. The antioxidant effects of statins may extend beyond atherosclerosis: potential benefits for atrial fibrillation and heart failure. Atherosclerosis. 2004 ; 175: 175-187
9. Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest. 2001 ; 108: 1429-1437 (Pubitemid 33091980)
10. Zenebe WJ, Nazarewicz RR, Parihar MS, Ghafourifar P. Hypoxia/ reoxygenation of isolated rat heart mitochondria causes cytochrome c release and oxidative stress; evidence for involvement of mitochondrial nitric oxide synthase. J Mol Cell Cardiol. 2007 ; 43: 411-419 (Pubitemid 47451417)
11. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007 ; 39: 44-84 (Pubitemid 44566469)
12. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005 ; 120: 483-495 (Pubitemid 40269763)
13. Velho JA, Okanobo H, Degasperi GR, Matsumoto MY, Alberici LC, Cosso RG, et al. Statins induce calcium-dependent mitochondrial permeability transition. Toxicology. 2006 ; 219: 124-132 (Pubitemid 43120712)
14. Sirvent P, Mercier J, Lacampagne A. New insights into mechanisms of statin-associated myotoxicity. Curr Opin Pharmacol. 2008 ; 8: 333-338
15. Pienaar IS, Schallert T, Hattingh S, Daniels WM. Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration. J Neural Transm. 2009 ; 116: 791-806
16. Ito M, Adachi T, Pimentel DR, Ido Y, Colucci WS. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism. Circulation. 2004 ; 110: 412-418 (Pubitemid 38993850)
17. Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation. 2004 ; 110: 856-861 (Pubitemid 39096015)
18. Cafforio P, Dammacco F, Gernone A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis. 2005 ; 26: 883-891 (Pubitemid 41214316)
19. Kaneko R, Tsuji N, Asanuma K, Tanabe H, Kobayashi D, Watanabe N. Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer. J Biol Chem. 2007 ; 282: 19273-19281 (Pubitemid 47100098)
20. Werner M, Sacher J, Hohenegger M. Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol. 2004 ; 143: 715-724 (Pubitemid 39611607)
21. Dirks AJ, Jones KM. Statin-induced apoptosis and skeletal myopathy. Am J Physiol Cell Physiol. 2006 ; 291: C1208 - C1212
22. Wagner BK, Kitami T, Gilbert TJ, Peck D, Ramanathan A, Schreiber SL, et al. Large-scale chemical dissection of mitochondrial function. Nat Biotechnol. 2008 ; 26: 343-351 (Pubitemid 351355127)
23. Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008 ; 8: 373-341
24. Ghafourifar P, Asbury ML, Joshi SS, Kincaid ED. Determination of mitochondrial nitric oxide synthase activity. Methods Enzymol. 2005 ; 396: 424-444 (Pubitemid 41603565)
25. Ghafourifar P, Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 1997 ; 418: 291-296 (Pubitemid 27515942)
26. Ghafourifar P, Schenk U, Klein SD, Richter C. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J Biol Chem. 1999 ; 274: 31185-31188
27. Ghafourifar P, Klein SD, Schucht O, Schenk U, Pruschy M, Rocha S, et al. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state. J Biol Chem. 1999 ; 274: 6080-6084
28. Klein SD, Walt H, Richter C. Photosensitization of isolated rat liver mitochondria by tetra(m-hydroxyphenyl)chlorine. Arch Biochem Biophys. 1997 ; 348: 313-319 (Pubitemid 28028482)
29. Ruiz-Meana M, Garcia-Dorado D, Miro-Casas E, Abellan A, Soler-Soler J. Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovasc Res. 2006 ; 71: 715-724 (Pubitemid 44848013)
30. Ghafourifar P, Parihar MS, Nazarewicz R, Zenebe WJ, Parihar A. Detection assays for determination of mitochondrial nitric oxide synthase activity; advantages and limitations. Methods Enzymol. 2008 ; 440: 317-334
31. Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002 ; 22: 300-305 (Pubitemid 34127043)
32. Vercesi AE, Kowaltowski AJ, Grijalba MT, Meinicke AR, Castilho RF. The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep. 1997 ; 17: 43-52 (Pubitemid 27267591)
33. Di Lisa F, Kaludercic N, Carpi A, Menabo R, Giorgio M. Mitochondria and vascular pathology. Pharmacol Rep. 2009 ; 61: 123-130
34. Nazarewicz RR, Zenebe WJ, Parihar A, Larson SK, Alidema E, Choi J, et al. Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res. 2007 ; 67: 1282-1290
35. Petrosillo G, Ruggiero FM, Pistolese M, Paradies G. Ca2+ induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin. J Biol Chem. 2004 ; 279: 53103-53108 (Pubitemid 40051811)
36. Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff DE. Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets. Transplantation. 2002 ; 74: 1063-1069 (Pubitemid 35216096)
37. Xu R, Chen J, Cong X, Hu S, Chen X. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. J Cell Biochem. 2008 ; 103: 256-269
38. Li Y, Boehning DF, Qian T, Popov VL, Weinman SA. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J. 2007 ; 21: 2474-2485 (Pubitemid 47230677)
39. Radi R, Bush KM, Cosgrove TP, Freeman BA. Reaction of xanthine oxidase-derived oxidants with lipid and protein of human plasma. Arch Biochem Biophys. 1991 ; 286: 117-125
40. Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, et al. Fluvastatin, a 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation. 2002 ; 105: 868-873 (Pubitemid 34174929)
41. Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology. 2007 ; 230: 256-264 (Pubitemid 46109145)
42. Rikitake Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, et al. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 2001 ; 154: 87-96 (Pubitemid 32008567)
43. Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol. 2000 ; 20: 61-69 (Pubitemid 30048347)
44. Ashraf M, Bloor CM. X-ray microanalysis of mitochondrial deposits in ischemic myocardium. Virchows Arch B Cell Pathol. 1976 ; 22: 287-297